Author:
Jarvis Lisa,Becker Janine,Tender Alzira,Cleland Alexander,Queiros Lucinda,Aquiar Ana,Azevedo Joana,Aprili Giuseppe,Bressan Fausto,Torres Pilar,Nieto Serafin,Ursitti Antonella,Montoro Jose,Vila Enrique,Ramada Concha,Saldanha John
Subject
Hematology,Immunology,Immunology and Allergy
Reference15 articles.
1. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing;Stramer;N Engl J Med,2004
2. 2. European Agency for the Evaluation of Medicinal Products: Committee for Proprietary Medicinal Products. The introduction of nucleic acid amplification technology (NAT) for the detection of hepatitis c virus RNA in plasma pools. 1998 Mar 24. Report No.: (CPMP/BWP/390/97).
3. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003;Coste;Vox Sang,2005
4. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe;Roth;Transfusion,2002
5. Scottish experience with NAT;Jarvis;Transfus Med,2002
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献